Eagle Pharmaceuticals, Inc.

549300TN20OLYTJVP152

The entity

Status: Active
LEI status: Lapsed - not renewed
Category: Company
Legal form: Corporation (XTIQ)
Jurisdiction: US-DE
Entity created: December 20, 2013

Address

Country: United States
Legal address: C/O CORPORATION SERVICE COMPANY19808 WILMINGTONUnited States (US-DE)
Head office: 50 Tice Boulevard07677 Woodcliff LakeUnited States (US-NJ)

Identifier

LEI: 549300TN20OLYTJVP152
Registered: December 20, 2013 at 03:01 AM UTC
Last updated: August 4, 2023 at 05:21 PM UTC
Next renewal: March 9, 2023 at 06:36 PM UTC
Issuer: Bloomberg (5493001KJTIIGC8Y1R12)
Registered with: Division of Corporations, Department of State (RA000602)
Identifier: 4260246
Verified against: Division of Corporations, Department of State (RA000602)
Verified as: 4260246
Corroboration: Confirmed against a public register
GLEIF conformity: Does not meet the standard

Corporate structure

Why no parent is reported

No direct parent reportedNo ultimate parent reported: No parent prepares consolidated accounts including it

Machine access

REST: https://lei.online/v1/entities/549300TN20OLYTJVP152This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search